Invitrogen Corp. is in the Pharma Industry

• Sort by

• Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research

  Invitrogen to become exclusive North American Distributor

  Research articles 2008-04-09

  Tags: Invitrogen Corp., team

• Invitrogen Teams with Genisphere to Advance Epigenetic Research

  Companies Offer New MicroRNA Labeling and Detection Kits

  Research articles 2008-02-27

  Tags: Invitrogen Corp., team

• Invitrogen Teams with Major Clinical Research Institution to Develop Biomarkers for Cancer Diagnosis and Disease Detection

  CARLSBAD, Calif. & ROCHESTER, Minn. -- Collaborative Research Agreement Combines Mayo Clinic Resources and Expertise with Invitrogen Technologies

  Research articles 2004-12-06

  Tags: Invitrogen Corp., team

Additional Resources

• Invitrogen, BayBio Sign Partnership Agreement

  CARLSBAD, Calif. & SOUTH SAN FRANCISCO, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced today its partnership with BayBio, a leading voice for the life sciences industry in Northern California. "BayBio is a vital voice for California's life...

  Articles 2008-11-11

• Invitrogen and Applied Biosystems Announce European Commission Merger Clearance

  Closing Date of Merger Scheduled for November 21, 2008; Deadline for Merger Consideration Elections to be Close of Business on November 19, 2008 CARLSBAD, Calif. & NORWALK, Conn. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have received clearance from the European Commission...

  Articles 2008-11-11

• Invitrogen Launches Microarray to Study Non-Coding RNA

  Agilent Technologies to Manufacture Unique Array for Invitrogen CARLSBAD, Calif. & SANTA CLARA, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs. The NCode[TM] Human...

  Articles 2008-11-06

• Invitrogen Provides Update on Merger with Applied Biosystems

  Three Applied Biosystems Board Members Named to New Board New Name Chosen for Combined Company CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) today announced progress against its integration plans regarding its pending merger with Applied Biosystems. The company announced that three members of the Applied...

  Articles 2008-11-04

• Beacon Equity Issues Technical Trade Alerts on Recent Analyst Upgrades: IVGN, DENN, POT, NOK, CP, MF

  DALLAS, Oct. 30 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Invitrogen Corp. , Denny's Corp. , Potash Corp. of Saskatchewan...

  Articles 2008-10-30

• Applied Biosystems Stockholders Approve Merger with Invitrogen

  NORWALK, Conn. -- Applied Biosystems Inc. (NYSE:ABI) today announced that its stockholders have voted to approve the company's proposed merger with Invitrogen Corporation (NASDAQ:IVGN) at a special meeting of stockholders held today. "We are pleased with the overwhelming support of this transaction by our stockholders," said Tony L....

  Articles 2008-10-28

• Invitrogen Shareholders Approve Merger with Applied Biosystems

  Company Provides Update on Merger CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ: IVGN) today announced that its shareholders have voted to approve the company's proposed merger with Applied Biosystems Inc. (NYSE: ABI) at a special meeting of shareholders held today. "We are pleased with the outcome of...

  Articles 2008-10-28

• Opportunities for Life Science Suppliers Plentiful in Rapidly Growing miRNA Research Markets

  MicroRNA miRNA Segment Leaders Invitrogen and Applied Biosystems Face Many Niche Competitors - Revealed in New miRNA Market Research Report from Percepta Associates CARLSBAD, Calif. -- Today Percepta Associates Inc. announced the release of MicroRNA Analysis in North America: A research market report for life science tool providers....

  Articles 2008-10-27

• Invitrogen Announces Third Quarter 2008 Financial Results

  Third quarter revenue of $362 million, 15 percent increase Third quarter GAAP EPS of $0.26 and non-GAAP EPS $0.69 Free cash flow $61 million for the quarter CARLSBAD, Calif. -- Invitrogen Corporation (Nasdaq:IVGN) today announced results for its third quarter ended September 30, 2008....

  Articles 2008-10-21

• Applied Biosystems Adjourns Special Meeting of Stockholders Until October 28, 2008; Votes, Proxies and Merger Consideration Elections Already Submitted Will Remain Valid

  Deadline for Cash, Stock, and Mixed Consideration Elections Expected to Be in November 2008 NORWALK, Conn. -- Consistent with its press release issued last week, Applied Biosystems Inc. (NYSE:ABI) adjourned Thursday's special meeting of stockholders relating to the pending merger with Invitrogen Corporation until 9:00 a.m. Eastern time...

  Articles 2008-10-20

• Invitrogen and Applied Biosystems Amend Merger Agreement to Eliminate Tax Opinion Condition; Stockholder Meetings to Be Moved to October 28, 2008

  CARLSBAD, Calif. & FOSTER CITY, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) and Applied Biosystems Inc. (NYSE:ABI) today announced that they have amended their pending merger agreement to eliminate a condition to closing requiring that the parties receive certain opinions of their respective counsel as to the tax treatment of the transaction....

  Articles 2008-10-15

• Invitrogen Launches Countess™

  Benchtop Instrument to Automate Cell Counting CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of a new benchtop instrument, Countess[TM] automated cell counter, which offers a new method of automated cell counting to replace...

  Articles 2008-10-10

• Invitrogen Congratulates Winners of Nobel Prize in Chemistry

  CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today congratulates the three winners of the 2008 Nobel Prize in chemistry: Drs. Roger Tsien, Osamu Shimomura and Martin Chalfie, all of whom contributed to developing and expanding the use of fluorescent...

  Articles 2008-10-09

• Invitrogen Announces Completion of Detailed Integration Plans Relating to Applied Biosystems Combination

  Company Provides Preview into Third Quarter 2008 Financial Results and Updates Post-Merger 2009 Guidance CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN) today announced that the company has completed a significant milestone in the integration planning for the Applied Biosystems combination. The company has finalized the synergy targets by identifying...

  Articles 2008-10-09

• Invitrogen Joins EPA's Climate Leaders Program

  CARLSBAD, Calif. -- As a part of its continued commitment to environmental sustainability, Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced its participation in the U.S. Environmental Protection Agency's (EPA's) Climate Leaders program. By participating in Climate Leaders, Invitrogen has pledged...

  Articles 2008-10-09

• Invitrogen Redesigns GIBCO® Bottle to Improve Form and Function

  CARLSBAD, Calif. -- Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, announced the global launch of its updated GIBCO cell culture media bottles. The new bottle design has an angled neck for easier pipetting and pouring; compact form for improved handling and storage;...

  Articles 2008-10-08

• Protein Linked to Spinal Muscular Atrophy Identified

  LIBERTYVILLE, Ill. & CARLSBAD, Calif. & WOODRIDGE, Ill. -- Families of Spinal Muscular Atrophy (FSMA, www.curesma.org), Invitrogen Corporation (NASDAQ:IVGN)(www.invitrogen.com), and deCODE chemistry & biostructures (www.decodechembio.com) announced today they have identified a protein that is a potential molecular target for the treatment of Spinal Muscular Atrophy SMA. In its most severe...

  Articles 2008-10-08